The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Treatment of depression: time to consider folic acid and vitamin B12
Abstract
We review the findings in major depression of a low plasma and particularly red cell folate, but also of low vitamin B12 status. Both low folate and low vitamin B12 status have been found in studies of depressive patients, and an association between depression and low levels of the two vitamins is found in studies of the general population. Low plasma or serum folate has also been found in patients with recurrent mood disorders treated by lithium. A link between depression and low folate has similalrly been found in patients with alcoholism. It is interesting to note that Hong Kong and Taiwan populations with traditional Chinese diets (rich in folate), including patients with major depression, have high serum folate concentrations. However, these countries have very low life time rates of major depression. Low folate levels are furthermore linked to a poor response to antidepressants, and treatment with folic acid is shown to improve response to antidepressants. A recent study also suggests that high vitamin B12 status may be associated with better treatment outcome. Folate and vitamin B12 are major determinants of one-carbon metabolism, in which S-adenosylmethionine (SAM) is formed. SAM donates methyl groups that are crucial for neurological function. Increased plasma homocysteine is a functional marker of both folate and vitamin B12 deficiency. Increased homocysteine levels are found in depressive patients. In a large population study from Norway increased plasma homocysteine was associated with increased risk of depression but not anxiety. There is now substantial evidence of a common decrease in serum/red blood cell folate, serum vitamin B12 and an increase in plasma homocysteine in depression. Furthermore, the MTHFR C677T polymorphism that impairs the homocysteine metabolism is shown to be overrepresented among depressive patients, which strengthens the association. On the basis of current data, we suggest that oral doses of both folic acid (800 µg daily) and vitamin B12 (1 mg daily) should be tried to improve treatment outcome in depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“The WHO ranks unipolar depression as the fourth most important cause of mortality and disability (Murray and Lopez, 1997).”
BackgroundCross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302
A Hundred Cases of Suicide: Clinical Aspects
Barraclough, B. M., Bunch, J., Nelson, B., & Sainsbury, P. (1974) · British Journal of Psychiatry · doi:10.1192/bjp.125.4.355 · Cited by 1,283
Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
Collaboration, H. L. T. (1998) · BMJ · doi:10.1136/bmj.316.7135.894 · Cited by 1,084
Facts and recommendations about total homocysteine determinations: an expert opinion
Refsum, H., Smith, A. D., Ueland, P. M., Nexo, E., Clarke, R., McPartlin, J., Johnston, C., Engbaek, F., Schneede, J., McPartlin, C., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.021634 · Cited by 1,056
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 1×
“Most consensus statements suggest continuation of treatment for 4–9 months after recovery and long-term maintenance treatment after three or more episodes (Geddes et al., 2003).”
BackgroundDepression and the Course of Coronary Artery Disease
Glassman, A. H., & Shapiro, P. A. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.4 · Cited by 676
Homocysteine, folate, methylation, and monoamine metabolism in depression
Bottiglieri, T. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.2.228 · Cited by 546
Vitamin B12, Folate, and Homocysteine in Depression: The Rotterdam Study
Tiemeier, H., van Tuijl, H. R., Hofman, A., Meijer, J., Kiliaan, A. J., & Breteler, M. M. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2099 · Cited by 408 · cited 1×
“Subjects with vitamin B12 deficiency were 70% more likely to have severe depressive disorder than subjects without deficiency (Tiemeier et al., 2002).”
BackgroundEnhancement of recovery from psychiatric illness by methylfolate
Godfrey, P. S. A., Toone, B. K., Bottiglien, T., Laundy, M., Reynolds, E. H., Carney, M. W. P., Flynn, T. G., & Chanarin, I. (1990) · The Lancet · doi:10.1016/0140-6736(90)91942-4 · Cited by 389
Cited by
New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?
Fardet, A. (2010) · Nutrition Research Reviews · doi:10.1017/s0954422410000041 · Cited by 1,030
Effects of Vitamin B 12 and Folate Deficiency on Brain Development in Children
Black, M. M. (2008) · Food and Nutrition Bulletin · doi:10.1177/15648265080292s117 · Cited by 393
Gilbody, S., Lewis, S., & Lightfoot, T. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj347 · Cited by 357
Singh, M. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00925 · Cited by 337
Perinatal Depression: Prevalence, Risks, and the Nutrition Link—A Review of the Literature
Leung, B. M. Y., & Kaplan, B. J. (2009) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2009.06.368 · Cited by 306
Metadata
- Authors
- Coppen, A., & Bolander-Gouaille, C.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2005-01
- Volume
- 19
- Issue
- 1
- Pages
- 59-65
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2123593284
- Cited by
- 373
- References
- 61
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of depression: time to consider folic acid and vitamin B12. https://app.cochat.ai/papers/10.1177/0269881105048899
- The paper
- Coppen, A., & Bolander-Gouaille, C. (2005). Treatment of depression: time to consider folic acid and vitamin B12. Journal of Psychopharmacology. https://doi.org/10.1177/0269881105048899
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.